{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:18:32Z","timestamp":1787800712407,"version":"build-2784847793"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16366-8","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T09:31:48Z","timestamp":1781775108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Screening of cytochrome CYP26A1 expression in different bone tumors"],"prefix":"10.1186","volume":"26","author":[{"given":"Belal","family":"Al-zu\u2019bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemah O. F. O.","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa","family":"AlQaisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed. A.","family":"Al-abadleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas O.","family":"Satari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameeh","family":"Al-Sarayreh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef M.","family":"Al-saraireh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Salem","family":"Hareedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"16366_CR1","unstructured":"American Cancer S. Key statistics about bone cancer. Am Cancer Soc. 2025. https:\/\/www.cancer.org\/cancer\/types\/bone-cancer\/key-statistics.html."},{"key":"16366_CR2","unstructured":"National Cancer I. SEER cancer stat facts: bone and joint cancer. 2025."},{"issue":"4","key":"16366_CR3","first-page":"205","volume":"98","author":"JL Ferguson","year":"2018","unstructured":"Ferguson JL, Turner SP. Bone cancer: diagnosis and treatment principles. Am Fam Physician. 2018;98(4):205\u201313.","journal-title":"Am Fam Physician"},{"key":"16366_CR4","doi-asserted-by":"crossref","unstructured":"Al-Zu'bi B, et al., Expression and clinical significance of cytochrome 1B1 in Bone Sarcomas. Pharmaceuticals (Basel), 2025;18(10).","DOI":"10.3390\/ph18101559"},{"key":"16366_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/bs.apha.2015.04.006","volume":"74","author":"F Stevison","year":"2015","unstructured":"Stevison F, et al. Role of Retinoic acid-metabolizing cytochrome P450s, CYP26, in inflammation and cancer. Adv Pharmacol. 2015;74:373\u2013412.","journal-title":"Adv Pharmacol"},{"key":"16366_CR6","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3332\/ecancer.2020.1114","volume":"14","author":"YM Al-Saraireh","year":"2020","unstructured":"Al-Saraireh YM, et al. Screening of cytochrome 4Z1 expression in human non-neoplastic, pre-neoplastic and neoplastic tissues. Ecancermedicalscience. 2020;14:1114.","journal-title":"Ecancermedicalscience"},{"key":"16366_CR7","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.2147\/OTT.S332037","volume":"14","author":"YM Al-Saraireh","year":"2021","unstructured":"Al-Saraireh YM, et al. Cytochrome 4Z1 expression is associated with poor prognosis in colon cancer patients. Onco Targets Ther. 2021;14:5249\u201360.","journal-title":"Onco Targets Ther"},{"key":"16366_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11112898","author":"YM Al-Saraireh","year":"2023","unstructured":"Al-Saraireh YM, et al. Targeting cytochrome P450 enzymes in ovarian cancers: new approaches to tumor-selective intervention. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11112898.","journal-title":"Biomedicines"},{"key":"16366_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58091263","author":"YM Al-Saraireh","year":"2022","unstructured":"Al-Saraireh YM, et al. Cytochrome 4Z1 expression connotes unfavorable prognosis in ovarian cancers. Medicina (Kaunas). 2022. https:\/\/doi.org\/10.3390\/medicina58091263.","journal-title":"Medicina (Kaunas)"},{"issue":"4","key":"16366_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41435-025-00342-6","volume":"26","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, et al. Folate metabolism-associated CYP26A1 is a clinico-immune target in colorectal cancer. Genes Immun. 2025;26(4):376\u201393.","journal-title":"Genes Immun"},{"key":"16366_CR11","doi-asserted-by":"publisher","first-page":"5286820","DOI":"10.1155\/2022\/5286820","volume":"2022","author":"Y Yu","year":"2022","unstructured":"Yu Y, et al. CYP26A1 is a novel cancer biomarker of pancreatic carcinoma: evidence from integration analysis and in vitro experiments. Dis Markers. 2022;2022:5286820.","journal-title":"Dis Markers"},{"issue":"10","key":"16366_CR12","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.21873\/anticanres.17249","volume":"44","author":"RS Issa","year":"2024","unstructured":"Issa RS, et al. Enhancing retinoic acid-mediated effects through inhibition of CYP26A1, CYP26B1 and HGF signaling in neuroblastoma cells. Anticancer Res. 2024;44(10):4189\u2013202.","journal-title":"Anticancer Res"},{"issue":"5","key":"16366_CR13","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.3390\/cimb46050246","volume":"46","author":"ME Battistella","year":"2024","unstructured":"Battistella ME, et al. Stemness and cell cycle regulators and their modulation by retinoic acid in ewing sarcoma. Curr Issues Mol Biol. 2024;46(5):3990\u20134003.","journal-title":"Curr Issues Mol Biol"},{"issue":"15","key":"16366_CR14","doi-asserted-by":"publisher","first-page":"12089","DOI":"10.3390\/ijms241512089","volume":"24","author":"G Brown","year":"2023","unstructured":"Brown G. Deregulation of all-trans retinoic acid signaling and development in cancer. Int J Mol Sci. 2023;24(15):12089.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"16366_CR15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/cancers16020264","volume":"16","author":"COB Facey","year":"2024","unstructured":"Facey COB, et al. CYP26A1 Links WNT and retinoic acid signaling: a target to differentiate ALDH+ stem cells in APC-Mutant CRC. Cancers. 2024;16(2):264.","journal-title":"Cancers"},{"issue":"1","key":"16366_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.yexcr.2016.12.007","volume":"350","author":"AC Green","year":"2017","unstructured":"Green AC, et al. Retinoic acid receptor signalling directly regulates osteoblast and adipocyte differentiation from mesenchymal progenitor cells. Exp Cell Res. 2017;350(1):284\u201397.","journal-title":"Exp Cell Res"},{"key":"16366_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26061757","author":"MMF Yee","year":"2021","unstructured":"Yee MMF, et al. Vitamin A and bone health: a review on current evidence. Molecules. 2021. https:\/\/doi.org\/10.3390\/molecules26061757.","journal-title":"Molecules"},{"key":"16366_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-pathol-011110-130303","volume":"6","author":"XH Tang","year":"2011","unstructured":"Tang XH, Gudas LJ. Retinoids, retinoic acid receptors, and cancer. Annu Rev Pathol. 2011;6:345\u201364.","journal-title":"Annu Rev Pathol"},{"key":"16366_CR19","doi-asserted-by":"publisher","first-page":"1254612","DOI":"10.3389\/fcell.2023.1254612","volume":"11","author":"K Lavudi","year":"2023","unstructured":"Lavudi K, et al. Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers. Front Cell Dev Biol. 2023;11:1254612.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"16366_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/biomedicines9030290","volume":"9","author":"S Sneha","year":"2021","unstructured":"Sneha S, et al. Intratumoural cytochrome P450 expression in breast cancer: impact on standard of care treatment and new efforts to develop tumour-selective therapies. Biomedicines. 2021;9(3):290.","journal-title":"Biomedicines"},{"issue":"3","key":"16366_CR21","doi-asserted-by":"publisher","first-page":"e90776","DOI":"10.1371\/journal.pone.0090776","volume":"9","author":"GT Brown","year":"2014","unstructured":"Brown GT, et al. The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancer. PLoS ONE. 2014;9(3):e90776.","journal-title":"PLoS ONE"},{"key":"16366_CR22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1186\/1756-0500-7-697","volume":"7","author":"M Osanai","year":"2014","unstructured":"Osanai M, Lee GH. Increased expression of the retinoic acid-metabolizing enzyme CYP26A1 during the progression of cervical squamous neoplasia and head and neck cancer. BMC Res Notes. 2014;7:697.","journal-title":"BMC Res Notes"},{"issue":"7","key":"16366_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1158\/2326-6066.CIR-16-0259","volume":"5","author":"Q Zhou","year":"2017","unstructured":"Zhou Q, et al. All-Trans retinoic acid prevents osteosarcoma metastasis by inhibiting M2 polarization of tumor-associated macrophages. Cancer Immunol Res. 2017;5(7):547\u201359.","journal-title":"Cancer Immunol Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16366-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16366-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16366-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:35:19Z","timestamp":1787798119000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16366-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16366"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16366-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed and approved by the Institutional Review and Ethics Committee of the Faculty of Medicine, Mutah University, Jordan (Reference No. 43025; approved on 15 June 2025). The study was conducted in accordance with the ethical principles of the Declaration of Helsinki and applicable institutional guidelines and regulations. Patient informed consent was waived by the Ethics Committee because the study utilized commercially available, fully anonymized tissue microarray specimens and involved no direct patient contact or identifiable patient information.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1027"}}